Cold agglutinin autoimmune haemolytic anaemia associated with novel coronavirus (COVID‐19)
Authors:
Open Access
- 27 May 2020
- journal article
- letter
- Published by Wiley in British Journal of Haematology
- Vol. 190 (4) , E183-E184
Abstract
Cold agglutinin syndrome (CAS) is a rare disorder associated with infection, autoimmune disorders, and lymphoid malignancies. We are present a case of CAS associated with SARS‐CoV‐2 that causes COVID‐19. A 46‐year‐old female presented with severe anemia and positive SARS‐CoV‐2 RNA PCR. Direct Coombs test was positive to IgG and complement. LDH was elevated and haptoglobin was undetectable. Peripheral smear revealed RBC agglutination, marked polychromasia, and many nucleated RBCs. Unfortunately, as a result of her severe hypoxemia, patient went into pulseless electrical activity before receiving transfusion and subsequently died. We postulate that CAS can be associated with COVID‐19, and ongoing surveillance is required for potential association.Keywords
This publication has 8 references indexed in Scilit:
- Incidence of thrombotic complications in critically ill ICU patients with COVID-19Thrombosis Research, 2020
- Autoimmune haemolytic anaemia associated with COVID‐19 infectionBritish Journal of Haematology, 2020
- Evans syndrome in a patient with COVID‐19British Journal of Haematology, 2020
- Diagnosis and treatment of autoimmune hemolytic anemia in adults: Recommendations from the First International Consensus MeetingBlood Reviews, 2020
- Immune Thrombocytopenic Purpura in a Patient with Covid-19New England Journal of Medicine, 2020
- Coagulopathy and Antiphospholipid Antibodies in Patients with Covid-19New England Journal of Medicine, 2020
- New Insights in the Pathogenesis and Therapy of Cold Agglutinin-Mediated Autoimmune Hemolytic AnemiaFrontiers in Immunology, 2020
- Cold agglutinin diseaseBlood, 2013